Tag: Human Papillomavirus (HPV)
CDC: Recent Decline Seen in High-Grade Cervical Lesions
Vast majority of cervical precancer cases attributable to HPV types targeted by 9-valent HPV vaccine
Histologic Clearance of CIN2/3 Seen With HPV Therapeutic Vaccine
In phase II trial, rate of complete resolution of CIN2/3 significantly higher for vaccine versus placebo group
Drop Seen in Preinvasive Cervical Disease With HPV Vaccination
Vaccine effectiveness increased for immunization at younger age
AACR: HPV Vax Low for Adults at High Risk for HIV Infection
Age, sex, sexual orientation differences in HPV vaccination rates were statistically significant
HPV Infection Unlikely to Spread From Hand Contact
Risk for new infection largely due to partners' genital HPV infection, not virus detectable on hands
Decline Observed in HPV Type 16/18 Cervical Precancers in U.S.
Greatest declines seen among vaccinated women; decreases also seen in unvaccinated women
44.4 Million Estimated to Be Diagnosed With Cervical Cancer by 2069
From 2020 to 2069, 6.7 to 7.7 million cases could be averted by scaling up HPV vaccination by 2020
Glottic Carcinoma Can Be HPV-Related Disease in Young Adults
Cases of glottic carcinoma in patients aged 30 years or younger tested positive for high-risk HPV
High-Risk HPV Infection Linked to Increased Risk for CVD in Women
High-risk HPV-CVD association stronger for those with obesity or metabolic syndrome
HPV Educational Video May Increase Vaccination Rates
Adolescents whose parents watched the video were three times more likely to be vaccinated
